Virtual Therapy in Rehabilitation Spastic Hemiparesis

NCT ID: NCT02061371

Last Updated: 2014-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluate the effectiveness of virtual therapy and conventional physiotherapy in spastic muscles of patients with sequelae of stroke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Considered the second most frequent cause of death worldwide , the stroke is also responsible for the largest number of functional disability in individuals. The socio - economic hardship that many patients face to perform a program of intensive rehabilitation sensorimotor, has led to functional limitations in many cases , promote irreversible consequences. Spasticity in the upper and lower limb after stroke results in loss of function and mobility being the key therapeutic approaches in order to restore its function. Currently, the Virtual therapy has been used in physical therapy, demonstrating safety, feasibility and potential to facilitate the effective rehabilitation treatment, promoting motor recovery. The objective of this study is to analyze and compare the effectiveness of virtual therapy and conventional physiotherapy in paretic upper and lower limbs of patients with sensory motor deficit after stroke. Virtual therapy will be based on a custom application using virtual reality projection, and conventional treatment will be based on cinesiotherapy for members upper and lower paretic. The evaluation will be performed by biomedical instrumentation using dynamometry, electromyography and analysis from functional movement. Statistical differences are based on t test with significance level of p 0 , 05 . As a result expected - scientifically proven the effectiveness of this new form of treatment aimed at improving quality of life and functional independence of patients with neurological sequel.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

virtual therapy

Group 1 (G1) included 20 patients who will carry out the virtual therapy.

Group Type EXPERIMENTAL

virtual therapy

Intervention Type OTHER

conventional physiotherapy

Group 2 (G2) included 20 patients who hold conventional physiotherapy.

Group Type EXPERIMENTAL

conventional physiotherapy

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

virtual therapy

Intervention Type OTHER

conventional physiotherapy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Medical referral for physiotherapy;
* Maximum grade 2 spasticity in the upper and lower limbs according to the Modified Ashworth Scale;
* Total passive range of elbow joint and knee to the movement of flexion and extension;
* Independent ambulation, with or without support;
* Cognitive preserved, being able to respond to the command of the examiner;
* Least 6 months of injury;

Exclusion Criteria

* Active infection, and rash at the site of application of NMES;
* Visual and hearing impairment;
* Joint stiffness and musculoskeletal injuries of the elbow and knee,
* Inability to interpret the therapeutic resources to be displayed;
* Presenting lesions in areas of Wernick and drill;
* Uncontrolled hypertension.
Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidade do Vale do Paraíba

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lersm, Ip&D

São José dos Campos, São Paulo, Brazil

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ana Carolina Borges, masters students

Role: CONTACT

5512981014448

Mário Oliveira Lima, professor

Role: CONTACT

551239471000 ext. 2066

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ana Carolina Borges, masters students

Role: primary

5512981014448

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20749113.5.0000.5503

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.